ArticleRevista panamericana de salud publica = Pan American journal of public health2026
[Compliance with drivers of the HEARTS-based integrated model for noncommunicable disease control in PeruNível de implementação dos fatores impulsionadores do modelo integrado para doenças não transmissíveis da iniciativa HEARTS no Peru].
Article in Revista panamericana de salud publica = Pan American journal of public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To describe compliance with the interventions defined as drivers of the HEARTS-based integrated model for noncommunicable disease control in Peru. Method: All Ministry of Health institutional health service providers (IHSPs) that are implementing the HEARTS initiative were invited to participate. The assessment was conducted between January and May 2025. Compliance was measured using the maturity index (MI), scored on a five-level scale ranging from incipient to fully mature. The percentage of IHSPs meeting the intervention targets for drivers of the MI for hypertension (HTN), type 2 diabetes mellitus (T2DM), and chronic kidney disease (CKD) was calculated. Results: Of 1000 IHSPs implementing the model, 92% reported their MIs for HTN, 92% for T2DM, and 93% for CKD. Overall, 82.3% of facilities were at maturity level 1 for HTN, 75% were at level 1 for T2DM, and 99.5% were at level 1 for CKD. For HTN, the target with the highest level of compliance was immediate initiation of pharmacological therapy, achieved by 75% of IHSPs. For T2DM, the targets most frequently met were timely delivery of screening results and early treatment optimization, achieved by 49% of IHSPs. For CKD, the target with the highest level of compliance was availability of a standardized treatment protocol, achieved by 17% of IHSPs. Conclusion: Although most IHSPs were only at the incipient maturity level, compliance was achieved for some interventions. Priority activities to improve care were identified.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.